CPT® Code 95133

1. Indications

The procedure of allergen immunotherapy using CPT® Code 95133 is indicated for patients who exhibit allergic reactions to stinging insects. The following conditions are typically associated with the need for this treatment:

• Allergic Reactions to Stinging Insects Patients who have a confirmed allergy to stinging insects such as bees, wasps, hornets, or yellow jackets, which may result in symptoms ranging from localized swelling and pain to more severe systemic reactions.

2. Procedure

The procedure for allergen immunotherapy, as described under CPT® Code 95133, involves several key steps that ensure the safe and effective administration of the allergenic extract:

• Step 1: Allergy Testing Prior to initiating immunotherapy, the patient undergoes allergy testing to identify specific stinging insect allergens. This testing is crucial for determining the appropriate allergenic extracts to be used in the immunotherapy regimen.
• Step 2: Development of Immunotherapy Schedule Based on the results of the allergy testing, a personalized immunotherapy schedule is developed. This schedule outlines the build-up and maintenance phases, detailing the frequency and dosage of allergenic extract injections.
• Step 3: Build-Up Phase Administration During the build-up phase, the patient receives small but progressively increasing doses of the allergenic extract. These injections are typically administered into the upper arm and occur one to three times per week over a period of 3 to 6 months. The goal of this phase is to gradually desensitize the patient's immune system to the identified allergens.
• Step 4: Maintenance Phase Administration After the build-up phase, the patient transitions to the maintenance phase, which involves monthly injections of the allergenic extract. This phase can last for 3 to 5 years, providing ongoing desensitization and reducing the severity of allergic reactions to stinging insects.
• Step 5: Monitoring and Follow-Up Throughout the treatment process, the patient is monitored for any adverse reactions to the injections and for the overall effectiveness of the immunotherapy. Follow-up appointments are scheduled to assess the patient's progress and make any necessary adjustments to the treatment plan.

3. Post-Procedure

After the administration of allergen immunotherapy, patients are typically advised to remain in the office or institution for a short period to monitor for any immediate allergic reactions. It is essential to observe the patient for signs of anaphylaxis or other adverse effects, especially following the initial doses during the build-up phase. Patients may experience mild side effects such as localized swelling or redness at the injection site, which are generally self-limiting. Education on recognizing symptoms of severe allergic reactions and the importance of adhering to the scheduled injections is also provided. Long-term follow-up is necessary to evaluate the effectiveness of the therapy and to determine if any adjustments to the treatment plan are required.